Clal Insurance’s Labcorp LH Stock Holding History

Clal Insurance’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,492	Closed	-$565K	–	151
2020 Q3	$565K	Hold	3,492	–	–	0.01%	111
2020 Q2	$498K	Buy	3,492 +582	+20%	+$80.5K	0.01%	116
2020 Q1	$316K	Buy	+2,910	New	+$419K	0.01%	115

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Clal Insurance's LH Position: Q4 2020 in Review

Clal Insurance sold out of Labcorp (LH) in Q4 2020, closing a stake of 3,492 shares — an estimated $565K sold.

Clal Insurance first reported a position in LH in Q1 2020 and held it in 3 quarters. The position peaked at $565K in Q3 2020. 906 funds tracked by Wall St. Rank hold LH as of Q4 2020.

Clal Insurance reported no remaining Labcorp position as of Q4 2020 after selling out during the quarter.
Clal Insurance sold 3,492 Labcorp shares in Q4 2020, an estimated $565K.
Clal Insurance first reported a position in Labcorp in Q1 2020 and held it in 3 quarters.
Clal Insurance's Labcorp position peaked at $565K in Q3 2020.
906 funds tracked by Wall St. Rank held Labcorp as of Q4 2020.

Based on Clal Insurance's 13F filing for Q4 2020, filed 16 Feb 2021.